{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:39:51Z","timestamp":1792712391680,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biocel.2026.107049","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:07:49Z","timestamp":1792249669000},"page":"107049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding RNAs in cancer treatment resistance: Mechanistic insights with a focus on circular RNAs"],"prefix":"10.1016","volume":"201","author":[{"given":"Ashiq","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaynaat","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Azmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khatoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Younas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manahil","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinza","family":"Ishaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2026.107049_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/nu13041212","article-title":"The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer","volume":"13","author":"Adinew","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biocel.2026.107049_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ncrna7020036","article-title":"Long non-coding RNA (lncRNA) roles in cell biology, neurodevelopment and neurological disorders","volume":"7","author":"Aliperti","year":"2021","journal-title":"Non-coding RNA"},{"key":"10.1016\/j.biocel.2026.107049_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2019.11.006","article-title":"Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems","volume":"25","author":"Alzhrani","year":"2020","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.biocel.2026.107049_bib4","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.3390\/ijms21176319","article-title":"Myeloid cell modulation by tumor-derived extracellular vesicles","volume":"21","author":"Arkhypov","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2026.107049_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","article-title":"Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy","volume":"23","author":"Chehelgerdi","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib6","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","article-title":"The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling","volume":"159","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2026.107049_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2026.107049_bib8","article-title":"Crosstalk between MicroRNAs and circular RNAs in human diseases: a bibliographic study","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biocel.2026.107049_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ceb.2018.02.011","article-title":"Post-transcriptional regulation of gene expression and human disease","volume":"52","author":"Corbett","year":"2018","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.biocel.2026.107049_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","article-title":"RNA modifications: importance in immune cell biology and related diseases","volume":"7","author":"Cui","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2026.107049_bib11","doi-asserted-by":"crossref","unstructured":"Dai, Y., Huang, Y., Wen, C., He, S., Shi, J., Wu, L., Zhou, H., 2019. CircSETD3 contributes to acquired resistance to gefitinib in non-small cell lung cancer by targeting miR-520h\/ABCG2 pathway. Available SSRN 3405549.","DOI":"10.2139\/ssrn.3405549"},{"key":"10.1016\/j.biocel.2026.107049_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.762185","article-title":"Identification of potential circRNA-microRNA-mRNA regulatory network in skeletal muscle","volume":"8","author":"Das","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biocel.2026.107049_bib13","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1002\/cam4.6600","article-title":"Roles of long noncoding RNA in triple-negative breast cancer","volume":"12","author":"Das","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.biocel.2026.107049_bib14","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6602573","article-title":"A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients","volume":"92","author":"De Vita","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib15","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","article-title":"Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2026.107049_bib16","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1158\/1078-0432.CCR-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Drayton","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2026.107049_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15476286.2016.1271524","article-title":"Insights into circular RNA biology","volume":"14","author":"Ebbesen","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.biocel.2026.107049_bib18","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway (s) and clinical outcome (s) association. Pathol. Pract","volume":"240","author":"El-Sheikh","year":"2022"},{"key":"10.1016\/j.biocel.2026.107049_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ncrna9050058","article-title":"The intergenic type LncRNA (LINC RNA) faces in cancer with in silico scope and a directed lens to LINC00511: a step toward ncRNA precision","volume":"9","author":"Eldash","year":"2023","journal-title":"Non-coding RNA"},{"key":"10.1016\/j.biocel.2026.107049_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1261\/rna.079554.122","article-title":"m6A-ELISA, a simple method for quantifying N6-methyladenosine from mRNA populations","volume":"29","author":"Ensinck","year":"2023","journal-title":"Rna"},{"key":"10.1016\/j.biocel.2026.107049_bib21","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.7150\/ijms.62219","article-title":"Circular RNAs interaction with MiRNAs: emerging roles in breast cancer","volume":"18","author":"Gong","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biocel.2026.107049_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ncrna9040038","article-title":"Functions of circular RNA in human diseases and illnesses","volume":"9","author":"Gu","year":"2023","journal-title":"Non-coding RNA"},{"key":"10.1016\/j.biocel.2026.107049_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-020-03302-2","article-title":"LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biocel.2026.107049_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105977","article-title":"m6A RNA methylation: from mechanisms to therapeutic potential","volume":"40","author":"He","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.biocel.2026.107049_bib25","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1038\/s41388-019-0747-0","article-title":"MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2026.107049_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41420-020-00387-8","article-title":"miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating \u03b2-catenin","volume":"7","author":"He","year":"2021","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.biocel.2026.107049_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41590-019-0400-7","article-title":"Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression","volume":"20","author":"Hu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biocel.2026.107049_bib28","article-title":"The role of non-coding RNAs in the sorafenib resistance of hepatocellular carcinoma","volume":"11","author":"Hu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib29","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181641","article-title":"Circular RNAs in gynecological disease: promising biomarkers and diagnostic targets","volume":"39","author":"Huang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biocel.2026.107049_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","article-title":"Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib31","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2026.107049_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104612","article-title":"Circular RNAs as key regulators in cancer hallmarks: new progress and therapeutic opportunities","volume":"207","author":"Hussen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biocel.2026.107049_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biocel.2026.107049_bib34","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s12276-024-01307-x","article-title":"The roles and mechanisms of coding and noncoding RNA variations in cancer","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biocel.2026.107049_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1634\/theoncologist.2010-0263","article-title":"Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities","volume":"16","author":"Kollmannsberger","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.biocel.2026.107049_bib36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1261\/rna.042143.113","article-title":"miR-139-5p is a regulator of metastatic pathways in breast cancer","volume":"19","author":"Krishnan","year":"2013","journal-title":"Rna"},{"key":"10.1016\/j.biocel.2026.107049_bib37","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1111\/cas.14617","article-title":"lncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biocel.2026.107049_bib38","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s11011-022-01069-3","article-title":"Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma","volume":"37","author":"Li","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biocel.2026.107049_bib39","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1038\/s41388-019-0926-z","article-title":"circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p\/PBLD axis in breast cancer","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2026.107049_bib40","article-title":"The role of circular RNAs in the drug resistance of cancers","volume":"11","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib41","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nm.4424","article-title":"lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt\/\u03b2-catenin signaling","volume":"23","author":"Lu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.biocel.2026.107049_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41420-021-00694-8","article-title":"Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p","volume":"7","author":"Ma","year":"2021","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.biocel.2026.107049_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.biocel.2026.107049_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.749753","article-title":"Competitive endogenous role of the LINC00511\/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis","volume":"11","author":"Mahmoud","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib45","doi-asserted-by":"crossref","first-page":"32093","DOI":"10.1074\/jbc.M703517200","article-title":"Mechanistic basis of differential cellular responses of phosphatidylinositol 3, 4-bisphosphate-and phosphatidylinositol 3, 4, 5-trisphosphate-binding pleckstrin homology domains","volume":"282","author":"Manna","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2026.107049_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.32604\/or.2022.027547","article-title":"circRNAs in drug resistance of breast cancer","volume":"30","author":"Misir","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.biocel.2026.107049_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12967-025-06629-6","article-title":"Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies","volume":"23","author":"Mu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biocel.2026.107049_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O\u2019Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biocel.2026.107049_bib49","article-title":"Roles and therapeutic implications of m6A modification in cancer immunotherapy","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2026.107049_bib50","first-page":"67","article-title":"Circular RNAs act as miRNA sponges","author":"Panda","year":"2018","journal-title":"Circ. RNAs Biog. Funct."},{"key":"10.1016\/j.biocel.2026.107049_bib51","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ymthe.2019.05.011","article-title":"circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p\/FOXO3a axis in breast cancer","volume":"27","author":"Sang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biocel.2026.107049_bib52","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.3390\/ijms24098095","article-title":"Interplay between LncRNAs and microRNAs in breast cancer","volume":"24","author":"Schwarzenbach","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2026.107049_bib53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1515\/med-2021-0355","article-title":"circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer","volume":"17","author":"Shi","year":"2022","journal-title":"Open. Med."},{"key":"10.1016\/j.biocel.2026.107049_bib54","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib55","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2026.107049_bib56","doi-asserted-by":"crossref","DOI":"10.3402\/ejpt.v5.25338","article-title":"Resilience definitions, theory, and challenges: interdisciplinary perspectives","volume":"5","author":"Southwick","year":"2014","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.biocel.2026.107049_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biocel.2026.107049_bib58","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial\u2013mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biocel.2026.107049_bib59","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biocel.2026.107049_bib60","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Reviews Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib61","article-title":"Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations","volume":"219","author":"Towers","year":"2019","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.biocel.2026.107049_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2026.107049_bib64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-031-45654-1_4","article-title":"Recent advances in RNA m6A modification in solid tumors and tumor immunity","author":"Verghese","year":"2023","journal-title":"Epigenetics Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2020.05.011","article-title":"The underlying mechanisms of noncoding RNAs in the chemoresistance of hepatocellular carcinoma","volume":"21","author":"Wang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biocel.2026.107049_bib66","article-title":"Advances in the study of CircRNAs in tumor drug resistance","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biocel.2026.107049_bib67","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug. Resist."},{"key":"10.1016\/j.biocel.2026.107049_bib68","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiaa264","article-title":"Protective activity of programmed cell death protein 1 blockade and synergy with caspofungin in a murine invasive pulmonary aspergillosis model","volume":"222","author":"Wurster","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biocel.2026.107049_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-019-1056-5","article-title":"A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1","volume":"18","author":"Xia","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib70","first-page":"673","article-title":"MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K\/Akt signaling pathway","volume":"68","author":"Xiao","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biocel.2026.107049_bib71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2026.107049_bib72","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gutjnl-2019-318830","article-title":"miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy","volume":"69","author":"Xu","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.biocel.2026.107049_bib73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3727\/096504018X15420734828058","article-title":"Hsa_circ_0003998 promotes chemoresistance via modulation of miR-326 in lung adenocarcinoma cells","volume":"27","author":"Yu","year":"2019","journal-title":"Oncol. Res."},{"key":"10.1016\/j.biocel.2026.107049_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41392-020-0182-2","article-title":"miR-410 induces both epithelial\u2013mesenchymal transition and radioresistance through activation of the PI3K\/mTOR pathway in non-small cell lung cancer","volume":"5","author":"Yuan","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2026.107049_bib75","doi-asserted-by":"crossref","DOI":"10.1515\/jib-2019-0027","article-title":"Non-coding RNAs and their integrated networks","volume":"16","author":"Zhang","year":"2019","journal-title":"J. Integr. Bioinform."},{"key":"10.1016\/j.biocel.2026.107049_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","article-title":"Role of non-coding RNAs and RNA modifiers in cancer therapy resistance","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.omtn.2019.07.012","article-title":"RETRACTED: circular RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in ovarian cancer via miR-1270 suppression","volume":"18","author":"Zhao","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biocel.2026.107049_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.35380","article-title":"Targeting fatty acid oxidation: A potential strategy for treating gastrointestinal tumors","volume":"157","author":"Zheng","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib79","article-title":"Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects","author":"Zhou","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2026.107049_bib80","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbrc.2018.11.157","article-title":"Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183\/PDPK1 signaling pathway","volume":"508","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:07:25Z","timestamp":1792710445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272526001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":80,"alternative-id":["S1357272526001597"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2026.107049","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in cancer treatment resistance: Mechanistic insights with a focus on circular RNAs","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2026.107049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107049"}}